DISCONTINUED OPERATIONS AND DECONSOLIDATION OF TRICHOME - Disclosure of results of discontinued operations (Details) - CAD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Jun. 30, 2023 |
Jun. 30, 2022 |
|||||
| Disclosure of analysis of single amount of discontinued operations [line items] | ||||||||
| Revenues | $ 13,207 | $ 12,703 | [1] | $ 25,736 | $ 25,704 | [1] | ||
| Cost of revenues | 9,473 | 10,108 | [1] | 18,759 | 20,023 | [1] | ||
| Gross profit | 3,734 | 2,595 | [1] | 6,977 | 5,681 | [1] | ||
| Fair value adjustments: | ||||||||
| Unrealized change in fair value of biological assets | 0 | 0 | [1] | 0 | (315) | [1] | ||
| Realized fair value adjustments on inventory sold in the year | (278) | (394) | [1] | (617) | (760) | [1] | ||
| Total fair value adjustments | (278) | (394) | [1] | (617) | (1,075) | [1] | ||
| Gross profit | 3,456 | 2,201 | [1] | 6,360 | 4,606 | [1] | ||
| General and administrative expenses | 2,389 | 3,337 | [1] | 5,563 | 7,284 | [1] | ||
| Selling and marketing expenses | 2,622 | 3,120 | [1] | 5,427 | 5,581 | [1] | ||
| Share-based compensation | (137) | 732 | [1] | 121 | 1,842 | [1] | ||
| Restructuring | 334 | 636 | [1] | 617 | 4,383 | [1] | ||
| Total operating expenses | 5,208 | 7,825 | [1] | 11,728 | 19,090 | [1] | ||
| Operating loss | (1,752) | (5,624) | [1] | (5,368) | (14,484) | [1] | ||
| Finance expenses, net | (2,114) | 1,030 | [1] | 621 | 2,583 | [1] | ||
| Loss before income taxes | (3,866) | (4,708) | [1] | (4,747) | (12,015) | [1] | ||
| Income tax expense (benefit) | (160) | (1,007) | [1] | (175) | (1,232) | [1] | ||
| Net loss from discontinued operations | $ 0 | (15,277) | [1] | $ 0 | (18,936) | [1] | ||
| Discontinued operations [member] | ||||||||
| Disclosure of analysis of single amount of discontinued operations [line items] | ||||||||
| Revenues | 11,118 | 21,686 | ||||||
| Cost of revenues | 8,100 | 15,399 | ||||||
| Gross profit | 3,018 | 6,287 | ||||||
| Fair value adjustments: | ||||||||
| Unrealized change in fair value of biological assets | 55 | 1,449 | ||||||
| Realized fair value adjustments on inventory sold in the year | (1,261) | (1,757) | ||||||
| Total fair value adjustments | (1,206) | (308) | ||||||
| Gross profit | 1,812 | 5,979 | ||||||
| General and administrative expenses | 7,844 | 12,942 | ||||||
| Selling and marketing expenses | 1,905 | 3,164 | ||||||
| Share-based compensation | 316 | 816 | ||||||
| Restructuring | 4,779 | 4,779 | ||||||
| Total operating expenses | 14,844 | 21,701 | ||||||
| Operating loss | (13,032) | (15,722) | ||||||
| Finance expenses, net | (2,416) | (3,413) | ||||||
| Loss before income taxes | (15,448) | (19,135) | ||||||
| Income tax expense (benefit) | (171) | (199) | ||||||
| Net loss from discontinued operations | $ (15,277) | $ (18,936) | ||||||
| ||||||||
| X | ||||||||||
- Definition The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
| X | ||||||||||
- Definition The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of income or cost associated with interest and other financing activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The gains (losses) arising from changes in fair value less costs to sell of biological assets due to both physical and price changes in the market. [Refer: Biological assets] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The gains (losses) excluding exchange differences, recognised in profit or loss, on the fair value measurement of assets. [Refer: At fair value [member]] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of expense relating to general and administrative activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of all operating expenses. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The profit (loss) before tax expense or income. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The profit (loss) from operating activities of the entity. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expense relating to the marketing and selling of goods or services. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Represents amount related to gross profit before fair value adjustment. No definition available.
|
| X | ||||||||||
- Definition Realized fair value adjustments on inventory sold in the period. No definition available.
|
| X | ||||||||||
- Definition The amounts represents restructuring expenses. No definition available.
|
| X | ||||||||||
- Details
|